Articles, guides, and regulatory updates from our community.
New research explores how IL-15 and Thymosin α1 may reduce immune aging in hepatocellular carcinoma. Learn what the findings mean for future cancer therapy.
By Peptide Association Research Team
New research explores how IL-15 and Thymosin α1 may reduce immune cell aging in liver cancer. Learn what this study found and what it means for patients.
By Peptide Association Research Team